MLTX icon

MoonLake Immunotherapeutics
MLTX

Overview Fund Activity

109 hedge funds and large institutions have $3.14B invested in MoonLake Immunotherapeutics in 2024 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 53 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
-2
Holders Change %
-1.8%
% of All Funds
1.58%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
17
Increased
53
Reduced
22
Closed
19
Calls
$6.05M
Puts
$5M
Net Calls
+$1.05M
Net Calls Change
+$2.79M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$250M
2
PBA
Paradigm Biocapital Advisors
New York
$47M
3
HRCM
Hood River Capital Management
Florida
$32.6M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$150M
5
VOYA Investment Management
VOYA Investment Management
Georgia
$20.6M

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
$25.5M
2
LGM
Logos Global Management
California
$0
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
$18.2M
4
Wellington Management Group
Wellington Management Group
Massachusetts
$9.68M
5
PCH
Polar Capital Holdings
United Kingdom
$25.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
BI
1
BVF Inc
California
$1.1B – – –
CAM
2
Cormorant Asset Management
Massachusetts
$428M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$250M +$65.9M +1,306,215 +36%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$150M +$21.1M +418,737 +16%
ACA
5
Avoro Capital Advisors
New York
$140M +$5.04K +100 +0%
Citadel Advisors
6
Citadel Advisors
Florida
$117M +$2.89M +57,276 +3%
Holocene Advisors
7
Holocene Advisors
New York
$79.9M -$2.08M -41,174 -3%
Goldman Sachs
8
Goldman Sachs
New York
$75.4M +$12.3M +244,084 +19%
Westfield Capital Management
9
Westfield Capital Management
Massachusetts
$58.9M +$2.51M +49,733 +4%
Marshall Wace
10
Marshall Wace
United Kingdom
$58.2M +$2.81M +55,755 +5%
Federated Hermes
11
Federated Hermes
Pennsylvania
$57M +$95.8K +1,900 +0.2%
AllianceBernstein
12
AllianceBernstein
Tennessee
$50.3M -$1.19M -23,610 -2%
PBA
13
Paradigm Biocapital Advisors
New York
$47M +$47M +931,480 New
FAM
14
Fred Alger Management
New York
$33.6M +$380K +7,545 +1%
HRCM
15
Hood River Capital Management
Florida
$32.6M +$32.6M +646,662 New
Nuveen Asset Management
16
Nuveen Asset Management
Illinois
$29.3M +$2.98M +59,076 +11%
Adage Capital Partners
17
Adage Capital Partners
Massachusetts
$25.5M -$66.6M -1,320,000 -72%
PCH
18
Polar Capital Holdings
United Kingdom
$25.2M -$8.98M -178,169 -26%
CCM
19
Camber Capital Management
Massachusetts
$22.2M +$4.34M +86,000 +24%
VOYA Investment Management
20
VOYA Investment Management
Georgia
$20.6M +$17.7M +350,958 +603%
BlackRock
21
BlackRock
New York
$20.2M +$442K +8,761 +2%
FC
22
Finepoint Capital
Massachusetts
$19.6M – – –
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
$18.2M -$11.3M -224,063 -38%
Pictet Asset Management
24
Pictet Asset Management
Switzerland
$18M +$554K +10,996 +3%
MB
25
MPM BioImpact
Massachusetts
$17.6M +$294K +5,828 +2%
1
2 3 4 5